trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['lung', 'destiny,lung 02']
since the director was sleeping, we did not see the slides in overflow areas and remotely .
but, gave an excellent discussion with the early - not so bad - results of destiny-lung 02. caution with ild, possibly dose-dependent. #esmo22 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
#liquidbiopsy~#screening~????